Results for time to onset is more variable translation from English to Danish

median time to onset was 10.0 weeks.
mediantiden til opståen var 10,0 uger.

the median time to onset was 7.5 days.
mediantiden indtil debut var 7,5 dage.

the median time to onset of rash was 10 days.
den mediane tid indtil udslæt var 10 dage.

the median time to onset was 6.7 weeks.
mediantiden til start var 6,7 uger.

time to onset of primary symptom relief (hrs)
tid til de primære symptomer begyndte at lindres (timer)

median time to onset of any grade leukopenia was 85 days.
mediantiden til leukopeni af en eller anden grad var 85 dage.

time to onset of symptom relief-- composite vas (hrs)
tid til symptomerne begyndte at lindres - sammensat vas (timer)

median time to onset was 0.5 months (range: 0.0-9.7).
mediantid til indtræden var 0,5 måneder (0,0-9,7).

the median time to onset of rash and diarrhoea was 10 days and 15 days, respectively.
den mediane tid til starten af udslæt og diarré var hhv.10 og 15 dage.

however, nationally the progress in implementation is more variable as shown in graph 1.
i de enkelte medlemsstater er der dog større udsving i arbejdet med gennemførelsen, hvilket fremgår af figur 1.

median time to onset of severe neutropenia was 9 days and the median duration was 7 days.
mediantiden til indtræden af alvorlig neutropeni var 9 dage, og medianvarigheden 7 dage.

the time to onset of symptoms varied from one day to several months after starting treatment.
tiden til symptomdebut varierede fra én dag til adskillige måneder efter behandlingsstart.

median time to onset was 10.5 weeks (range: 2.1-27.0).
mediantiden til indtræden var 10,5 uger (2,1-27,0).

(n = 56) median time to onset of symptom relief: all symptoms (hours):
(n = 56) mediantid til begyndelse af symptomlindring alle symptomer (t):

the median time to onset of hyperthyroidism was 1.4 months (range 1 day to 21.9 months).
den mediane tid til indtræden af hypertyroidisme var 1,4 måneder (interval: 1 dag til 21,9 måneder).

median time to onset of these endocrinopathies was 1.5 months (range: 0.0-10.1).
mediantid til indtræden af disse endokrinopatier var 1,5 måneder (0,0- 10,1).

median time to onset of these endocrinopathies was 17.8 weeks (range: 6.1-33.1).
mediantiden til indtræden af disse endokrinopatier var 17,8 uger (6,1-33,1).

autoimmune disorders (such as graves’ disease) have also been reported to occur in the setting of immune reactivation; however, the reported time to onset is more variable and these events can occur many months after initiation of treatment.
autoimmune lidelser (såsom graves sygdom) er også rapporteret i forbindelse med immunreaktivering. udbrudstidspunktet er dog mere variabelt og kan være mange måneder efter initiering af behandling.